Sami Labs acquires global marketing rights for Oroxylum Indicum from CSIR

Bengaluru: Sami Labs has acquired the exclusive Global Marketing Rights for European and USA patents on Oroxylum Indicum from the Council for Scientific and Industrial Research (CSIR) – Indian Institute of Chemical Technology, Hyderabad.

Oroxylum Indicum is a species of flowering plant belonging to the monotypic genus Oroxylum and the family Bignoniaceae, are commonly called midnight horror, Indian trumpet flower, broken bones, Indian caper, or tree of Damocles.

Among the various medicinal uses, the decoction of the bark from the plant is taken for curing gastric ulcer and a paste made of the bark powder is applied for mouth cancer, scabies and other skin diseases. The seed is ground with fire-soot and the paste applied to the neck for quick relief of tonsil pain. Also, a paste made of the bark is applied to the wounds of animals to kill maggots. Decoction of the bark is given to animals for de-worming. The plant is also claimed to have anti-cancer properties.

Dr Muhammed Majeed, Founder & Chairman Sami-Sabinsa Group signed the agreement with Dr D Shailaja, Head of Business Development and Research Management & Senior Principal Scientist, CSIR – Indian Institute of Chemical Technology at Sami Labs office Bengaluru.

“This achievement is a milestone in our collaboration as it accelerates our mission to provide quality products across the globe,” said Dr Majeed.

Sami Labs Limited is a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals and probiotics. The Government of India honored Sami Labs Limited with the National Award for Quality Products (Basic Drugs) in the year 1994 and the Prestigious DSIR award in the year 2002.

The CSIR-Indian Institute of Chemical Technology (CSIR-IICT) is one of the oldest National Laboratories under the Council of Scientific & Industrial Research (CSIR). CSIR-IICT during its seventy-year journey has made its mark as a dynamic, innovative and result in oriented R&D organization.